Elimination of certain in process or final device tests performed on avitene collagen hemostasis (mch) products. This will eliminate test redundancy, waste and/or provide a more efficient utilization of test samples selected during the processing of avitene.
Device | AVITENE MICROFIBRILLAR COLLAGEN HEMOSTAT (MCH) NON-WOVEN WEB |
Classification Name | Agent, Absorbable Hemostatic, Collagen Based |
Generic Name | Agent, Absorbable Hemostatic, Collagen Based |
Applicant | C.R. Bard, Inc. |
Date Received | 2001-05-23 |
Decision Date | 2001-06-18 |
PMA | P800002 |
Supplement | S012 |
Product Code | LMF |
Advisory Committee | General & Plastic Surgery |
Supplement Type | 30-day Notice |
Supplement Reason | Process Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | C.R. Bard, Inc. 160 New Boston Street woburn, MA 01801 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P800002 | | Original Filing |
S028 |
2021-01-19 |
30-day Notice |
S027 | | |
S026 |
2020-02-28 |
30-day Notice |
S025 |
2019-05-20 |
30-day Notice |
S024 |
2018-12-03 |
30-day Notice |
S023 |
2018-06-28 |
30-day Notice |
S022 |
2017-03-27 |
135 Review Track For 30-day Notice |
S021 |
2014-05-30 |
30-day Notice |
S020 |
2013-12-11 |
30-day Notice |
S019 |
2013-06-24 |
30-day Notice |
S018 |
2011-12-22 |
Special (immediate Track) |
S017 |
2011-09-02 |
30-day Notice |
S016 |
2009-03-20 |
30-day Notice |
S015 |
2005-09-08 |
30-day Notice |
S014 |
2004-10-04 |
30-day Notice |
S013 |
2003-06-11 |
30-day Notice |
S012 |
2001-05-23 |
30-day Notice |
S011 |
1998-07-21 |
30-day Notice |
S010 |
1993-12-02 |
Normal 180 Day Track |
S009 |
1992-01-21 |
Normal 180 Day Track |
S008 |
1991-10-16 |
Normal 180 Day Track |
S007 |
1988-03-08 |
Normal 180 Day Track |
S006 | | |
S005 |
1983-10-11 |
|
S004 |
1983-08-30 |
|
S003 |
1982-01-07 |
|
S002 |
1981-01-27 |
|
S001 |
1981-04-09 |
|
NIH GUDID Devices